Eye Co Pty Ltd is a Victorian based ocular drug development company, dedicated
to developing new treatments for blinding retinal diseases, especially those
associated with diabetes.
In 2012, the company won the prestigious Commercialization Australia grant, and forged a
number of new revenue and research partnerships with leading eye clinics and universities.
Eye Co was founded in 2006 by Prof Philip Penfold, an academic, inventor and author of a
leading book on Macular Degeneration.
Prof Penfold had invented a new, steroidal-based approach to "exudative" and "edematous"
eye disease, and filed a new set of patents on his novel approach to treating back of eye disease.